Seeking the mechanism(s) of action for corticosteroids in HELLP syndrome: SMASH study

American Journal of Obstetrics and Gynecology

Volumn 208, Issue 5, 2013, Pages 380.e1-380.e8

  Wallace, Kedra ^a   Martin Jr , James N ^a   Tam Tam, Kiran ^a   Wallukat, Gerd ^b   Dechend, Ralf ^b   Lamarca, Babbette ^a   Owens, Michelle Y ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome; inflammatory cytokines; severe preeclampsia; soluble endoglin; soluble fms like tyrosine kinase 1

Indexed keywords

ANGIOTENSIN RECEPTOR AUTOANTIBODY; ASPARTATE AMINOTRANSFERASE; CYTOKINE; DEXAMETHASONE; ENDOGLIN; FMS LIKE TYROSINE KINASE 1; HYDRALAZINE; INTERLEUKIN 6; LABETALOL; LACTATE DEHYDROGENASE; MAGNESIUM SULFATE; PLACENTAL GROWTH FACTOR; UNCLASSIFIED DRUG;

ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELLP SYNDROME; HEMOLYSIS; HUMAN; HYPERTENSION; LACTATE DEHYDROGENASE BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEIZURE; THROMBOCYTE; THROMBOCYTE COUNT;

EID: 84876677650     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2013.01.049     Document Type: Article

References (44)

1. M. Geary The HELLP syndrome Br J Obstet Gynaecol 104 1997 887 901
2. S. Karumanchi, S. Maynard, I. Stillman, F. Epstein, S. Sukhatme Preeclampsia: a renal perspective Kidney Int 67 2005 2101 2113
3. B. Sibai Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes and low platelet count Obstet Gynecol 103 2004 981 991
4. S. Keiser, M. Owens, M. Parrish HELLP syndrome with and without eclampsia Am J Perinatol 28 2011 187 194
5. J.J. Martin, E. Magann, C. Isler HELLP syndrome: the scope of disease and treatment S. Thornton, G. Saade, Hypertension in pregnancy 2003 Oxford Belfort
6. J.J. Martin, C. Rose, C. Briery Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child Am J Obstet Gynecol 195 2006 914 934
7. S. Maynard, J. Min, J. Merchan Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 2003 649 658
8. S. Venkatesha, M. Toporsian, C. Lam Soluble endoglin contributes to the pathogenesis of preeclampsia Nat Med 12 2006 642 649
9. Y. Zhou, M. McMaster, K. Woo Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes and low platelets syndrome Am J Pathol 160 2002 1405 1423
10. B. Xu, C. Thornton, J. Tooher, A. Hennessy Exogenous soluble VEGF receptor-1 (sFlt-1) regulates Th1/Th2 cytokine production from normal placental explants via intracellular calcium Hypertens Pregnancy 28 2009 448 456
11. B. LaMarca, W. Bennett, B. Alexander, K. Cockrell, J. Granger Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha Hypertension 46 2005 1022 1025
12. M. Parrish, S. Murphy, S. Rutland The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy Am J Hypertens 23 2010 911 916
13. W. Visser, I. Beckmann, H. Bremer, H. Lim, H. Wallenburg Bioactive tumour necrosis factor alpha in pre-eclamptic patients with and without the HELLP syndrome Br J Obstet Gynaecol 101 1994 1752 1757
14. A. Tranquilli, B. Landi, A. Corradetti Inflammatory cytokines patterns in the placenta of pregnancies complicated by HELLP (hemolysis, elevated liver enzyme, and low platelet) syndrome Cytokine 40 2007 82 88
15. P. van Runnard Heimel, A. Kavelaars, C. Heijnen HELLP syndrome is associated with an increased inflammatory response, which may be inhibited by administration of prednisolone Hypertens Pregnancy 27 2008 253 265
16. M. Kupferminc, A. Peaceman, T. Wigton, K. Rehnberg, M. Socol Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia Am J Obstet Gynecol 170 1994 1752 1757
17. R. Dechend, V. Homuth, G. Wallukat Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia J Soc Gynecol Investig 13 2006 79 86
18. C. Zhou, S. Ahmad, T. Mi Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling Hypertension 51 2008 1010 1019
19. L. Katz, M. de Amorim, J. Fiqueiroa, J. Pinto e Silva Postpartum dexamethasone for women with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a double-blind, placebo-controlled, randomized clinical trial Am J Obstet Gynecol 198 2008 1 8
20. J.J. Martin, M. Owens, S. Keiser Standardized Mississippi Protocol treatment of 190 patients with HELLP syndrome: slowing disease progression and preventing new major maternal morbidity Hypertens Pregnancy 31 2012 79 90
21. J. Fonseca, F. Mendez, C. Catano, F. Arias Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled randomized clinical trial Am J Obstet Gynecol 193 2005 1591 1598
22. J.J. Martin, B. Rinehart, W. May, E. Magann, D. Terrone, P. Blake The spectrum of severe preeclampsia: comparative analysis by HELLP syndrome classification Am J Obstet Gynecol 180 1999 1373 1384
23. G. Wallukat, V. Homuth, T. Fischer Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor J Clin Invest 103 1999 945 952
24. F. Herse, S. Verlohren, K. Wenzel Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study Hypertension 53 2009 393 398
25. S. Verlohren, I. Herraiz, O. Lapaire The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients Am J Obstet Gynecol 206 2012 58.e1 8
26. J.J. Martin, P. Blake, S. Lowery, K.J. Perry, J. Files, J. Morrison Pregnancy complicated by preeclampsia-eclampsia with HELLP syndrome: how rapid is postpartum recovery? Obstet Gynecol 76 1990 737 741
27. D. Altman, G. Carroli, L. Duley Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial Lancet 359 2002 1877 1890
28. A. Euser, M. Cipolla Resistance artery vasodilation to magnesium sulfate during pregnancy and the postpartum state Am J Physiol Heart Circ Physiol 288 2005 H1521 H1525
29. J.J. Martin, B. Thigpen, R. Moore, C. Rose, J. Cushman, W. May Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure Obstet Gynecol 105 2005 246 254
30. M. Llinas, G. Wallukat, D. Mueller Agonistic autoantibodies to the AT1 receptor in a rat model of preeclampsia induced by chronic reductions in uterine perfusion pressure (RUPP) Hypertension 46 2005 883
31. S. Murphy, B. LaMarca, K. Cockrell, J. Granger Role of endothelin in mediating soluble fms-like tyrosine kinase 1 induced hypertension in pregnant rats Hypertension 55 2010 394 398
32. P. Aggarwal, N. Chandel, V. Jain, V. Jha The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia J Hum Hypertens 26 2012 236 241
33. K. Tam Tam, B. Lamarca, M. Arany Role of reactive oxygen species during hypertension in response to chronic antiangiogenic factor (sFlt-1) excess in pregnant rats Am J Hypertens 24 2011 110 113
34. R. Levine, S. Maynard, C. Qian Circulating angiogenic factors and risk of preeclampsia N Engl J Med 350 2004 672 683
35. E. George, J. Granger Linking placental ischemia and hypertension in preeclampsia: role of endothelin 1 Hypertension 60 2012 507 511
36. B. LaMarca, M. Parrish, L. Ray Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: a role of endothelin-1 Hypertension 54 2009 905 909
37. B. Lamarca Endothelial dysfunction An important mediator in the pathophysiology of hypertension during pre-eclampsia Minerva Ginecol 64 2012 309 320
38. B. LaMarca, J. Brewer, K. Wallace IL-6 induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate? Int J Interferon Cytokine Mediator Res 3 2011 59 64
39. J. Meekins, P. McLaughlin, D. West, I. McFadyen, P. Johnson Endothelial cell activation by tumour necrosis factor-alpha (TNF-alpha) and the development of pre-eclampsia Clin Exp Immunol 98 1994 110 114
40. R. Taylor, M. Varma, N. Teng, J. Roberts Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies J Clin Endocrinol Metab 71 1990 1675 1677
41. S. Khedun, T. Naicker, J. Moodley Endothelin-1 activity in pregnancy J Obstet Gynaecol 22 2002 590 593
42. C. Giuliano, R. Smalligan, G. Mitchon, M. Chua Role of dexamethasone in the prevention of migraine recurrence in the acute care setting: a review Postgrad Med 124 2012 110 115
43. W. Wang, Y. Wang, X. Chen Dexamethasone attenuates development of monocrotaline-induced pulmonary arterial hypertension Mol Biol Rep 38 2011 3277 3284
44. N. Ekerbicer, S. Inan, F. Tarakc, T. Barut, T. Gurpinar, M. Ozbek Effects of acute treatment with dexamethasone on hemodynamic and histopathological changes in rats Biotech Histochem 87 2012 385 396